Glycorex Transplantation AB (NGM:GTAB B) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NGM:GTAB B Glycorex Transplantation AB NGM:GTAB B
61 GF Score
Price kr1.46
GF Value kr1.81
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Glycorex Transplantation AB FFO?

FFO (Funds from operations) only applies to REITs.

NGM:GTAB B
61GF Score
Glycorex Transplantation AB NGM:GTAB B
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Glycorex Transplantation AB (NGM:GTAB B) Overvalued in 2026?

Based on GuruFocus' analysis, Glycorex Transplantation AB stock appears to be undervalued. The current stock price of kr1.46 is trading 19.3% below its estimated GF Value™ of kr1.81. GuruFocus considers Glycorex Transplantation AB to be Modestly Undervalued.

Key valuation signals for NGM:GTAB B:

  • FFO:
  • GF Value™: kr1.81 vs. price of kr1.46 (19.3% below fair value)
  • GF Score™: 61/100 with 5 warning signs

No single metric tells the full story. See the NGM:GTAB B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Glycorex Transplantation AB Business Description

Other Exchanges O33:Germany
Address Scheelevagen 27, Lund, SWE, 223 63
Glycorex Transplantation AB is a medical technology company. Its main product Glycosorb ABO is used clinically in six continents to facilitate blood group incompatible transplants, especially in kidney transplants from related living donors, but also in transplantation of liver, heart, lung and stem cells. Glycosorb ABO enables grafts regardless of the blood group of donors and recipients. The product is used in extracorporeal blood treatment, that is, a blood treatment that takes place outside the body in the same way as dialysis. Its segment is research, develop, manufacture, market and sell products in the field of organ transplantation or related areas. Geographically it operates in Europe, Australia, Singapore, India, and Other countries with majority of revenue from Europe.
61GF Score

Get the complete analysis for NGM:GTAB B

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1.46
Price
kr1.81
GF Value